Walk It Off! the Influence of Physical Activity Level on the Recovery from Damaging Resistance Exercise (WIO)

January 30, 2025 updated by: Daniel Moore, University of Toronto
After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.

Study Overview

Detailed Description

Skeletal muscle pain and tenderness typically follow an unaccustomed bout of physical activity involving eccentric or lengthening contractions. The intensity of pain peaks between 24 and 72 h following the cessation of activity and subsides completely between 5 and 7 days after exercise. Delayed-onset muscle soreness (DOMS) refers to physical discomfort, while associated impairments to muscle strength and function reflect the occurrence of exercise-induced muscle damage (EIMD). The result is reduced performance and increased likelihood of further injury during the affected period. In beginners, DOMS may also reduce the likelihood of continuing exercise.

Despite its ubiquity in sport and exercise, the precise mechanism of DOMS remains uncertain. Potential mechanisms include EIMD, inflammation, and immune cell infiltration among others. More recently, evidence has emerged suggesting a greater role of intramuscular connective tissue damage in causing DOMS. Following an acute bout of eccentric exercise, the fascial connective tissue exhibits greater swelling than after a concentric exercise. Furthermore, this swelling was correlated with the severity of DOMS. This novel evidence may aid in directing strategies to mitigate the duration and severity of DOMS.

A variety of treatments for DOMS have been explored with varying degrees of efficacy. Massage has been shown to effectively mitigate DOMS following exercise as it passively increases muscle blood flow and reduces muscle oedema. Electrostimulation has also been shown to produce analgesic effects following unaccustomed exercise, although results are inconsistent. Differences in the treatment design may produce discrepant findings with longer duration, lower frequency stimulation alleviating DOMS, in contrast to shorter duration, higher frequency stimulation. Furthermore, lower-intensity longer-duration recovery modalities that promote muscle blood flow may partially ameliorate the ergolytic effects of DOMS. Based on these findings, active recovery consisting of low-intensity exercise following training which facilitates muscle blood flow might be expected to improve recovery from DOMS. However, active recovery strategies such as submaximal cycling or jogging following exercise has little effect on recovery from unaccustomed exercise. While these protocols do promote the muscle blood flow in the days following the bout of exercise, their intensity may be too great to allow for recovery of the muscle while their duration may be too low to produce a sustained effect. It has recently been shown that low daily step counts (<5000/day) can interfere with the normal recovery from aerobic exercise and reduce the normal benefits to metabolism, highlighting that our habitual activity levels might be the most important variable in recovering from and adapting to the stress of exercise. Therefore, the purpose of this study is to investigate the effect of high (>10,000 steps) and moderate (<5,000) daily step counts on recovery from an unaccustomed bout of resistance exercise.

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S2C9
        • Goldring Center for High Performance Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Healthy, recreationally active male and female participants (i.e., weekly MET-minutes > 3000 assessed by International Physical Activity Questionnaire).

Not having a health condition that would compromise their ability to safely participate in the strenuous physical activity involved in our study screened for by the get active questionnaire.

Between 18 and 35 years old.

Body mass index (BMI) between 18.5-30

Self-reported not having engaged in resistance exercise and/or lower body plyometrics for at least 3 months prior to the study.

Willing to abide by the compliance rules of this study.

Self-reported regular menstrual cycle (25-35d) within the last 3 months (female participants).

Exclusion Criteria:

Inability to adhere to any of the compliance rules judged by the principal investigator or medical doctor.

Self-reported regular tobacco use.

Regular use of non-steroidal anti-inflammatory drugs (e.g., Advil)

Use of oral contraceptives (female participants).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Activity
Requires completion of greater than 10,000 steps per day
150 maximal, unilateral eccentric contractions of the quadriceps muscles on a computerized dynamometer.
Experimental: Moderate Activity
Requires completion of less than 5,000 steps per day
150 maximal, unilateral eccentric contractions of the quadriceps muscles on a computerized dynamometer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximal muscle strength between physical activity levels
Time Frame: Daily assessment (every 24 hours) across 96 hours post-exercise
Maximal voluntary isometric and isokinetic contraction assessed by peak torque via computerized dynamometer.
Daily assessment (every 24 hours) across 96 hours post-exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delayed onset muscle soreness (DOMS)
Time Frame: Daily assessments (every 24 hours) across 96 hours post-exercise
Assessing DOMS by subjective pain assessments using a 10 centimetre visual analog scale following standardized movements (i.e., descend/ascend stairs, sit-to-stand), where a minimum of "0" reflects no pain, and maximum of "10" reflects the most pain imaginable. Units will be reported to the nearest millimetre.
Daily assessments (every 24 hours) across 96 hours post-exercise
Change in muscle and fascial connective tissue thickness
Time Frame: Daily assessment (every 24 hours) across 96 hours post-exercise
Assessing changes in vastus lateralis and rectus femoris muscle and fascial connective tissue thickness via ultrasonography.
Daily assessment (every 24 hours) across 96 hours post-exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2025

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

January 24, 2025

First Submitted That Met QC Criteria

January 30, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 30, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on Eccentric resistance exercise

Subscribe